Exact Mass: 386.29331279999997
Exact Mass Matches: 386.29331279999997
Found 500 metabolites which its exact mass value is equals to given mass value 386.29331279999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bufalin
Bufalin is a cardiotonic steroid toxin[1] originally isolated from Chinese toad venom, which is a component of some traditional Chinese medicines.[2][3] Bufalin has in vitro antitumor effects against various malignant cell lines, including hepatocellular[4] and lung carcinoma.[5] However, as with other bufadienolides, its potential use is hampered by its cardiotoxicity.[6] Bufalin is a 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo. It has a role as an antineoplastic agent, a cardiotonic drug, an anti-inflammatory agent and an animal metabolite. It is a 3beta-hydroxy steroid and a 14beta-hydroxy steroid. It is functionally related to a bufanolide. Bufalin is a natural product found in Cunninghamella blakesleeana, Bufo gargarizans, and other organisms with data available. Bufalin is an active ingredient and one of the glycosides in the traditional Chinese medicine ChanSu; it is also a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans, with potential cardiotonic and antineoplastic activity. Although the mechanism of action of bufalin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and can induce apoptosis in cancer cell lines through the activation of the transcription factor AP-1 via a mitogen activated protein kinase (MAPK) pathway. A 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo. Bufalin is an active component isolated from Chan Su, acts as a potent Na+/K+-ATPase inhibitor, binds to the subunit α1, α2 and α3, with Kd of 42.5, 45 and 40 nM, respectively[1][2]. Anti-cancer activity[2]. Bufalin is an active component isolated from Chan Su, acts as a potent Na+/K+-ATPase inhibitor, binds to the subunit α1, α2 and α3, with Kd of 42.5, 45 and 40 nM, respectively[1][2]. Anti-cancer activity[2].
Testosterone Isocaproate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Medroxyprogesteroneacetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents CONFIDENCE standard compound; INTERNAL_ID 8749 CONFIDENCE standard compound; INTERNAL_ID 2813 D000970 - Antineoplastic Agents Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1]. Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1].
12a-Hydroxy-3-oxocholadienic acid
12a-Hydroxy-3-oxocholadienic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.
Luffariellolide
8Z,11Z,14Z,17Z,20Z-hexacosapentaenoic acid
A very long-chain omega-6 fatty acid that is hexacosanoic acid containing five double bonds located at positions 8, 11, 14, 17 and 20 (the 8Z,11Z,14Z,17Z,20Z-isomer).
1-Phenyl-1,3-eicosanedione
1-Phenyl-1,3-eicosanedione is found in fats and oils. 1-Phenyl-1,3-eicosanedione is a constituent of the pollen of Helianthus annuus (sunflower). Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-eicosanedione is found in fats and oils.
Mangalkanyl glucoside
Mangalkanyl glucoside is found in fruits. Mangalkanyl glucoside is a constituent of the root bark of Mangifera indica (mango) Constituent of the root bark of Mangifera indica (mango). Mangalkanyl glucoside is found in fruits.
Cryptomeridiol 11-rhamnoside
Cryptomeridiol 11-rhamnoside is a constituent of fruits of Cananga odorata (ylang ylang). Constituent of fruits of Cananga odorata (ylang ylang)
MG(20:0/0:0/0:0)
MG(20:0/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(20:0/0:0/0:0) is made up of one eicosanoyl(R1).
MG(i-20:0/0:0/0:0)
MG(i-20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-20:0/0:0/0:0) is made up of one 18-methylnonadecanoyl(R1).
DG(O-18:0/2:0/0:0)
2-Acetyl-1-octadecyl-sn-glycerol, or DG(O-18:0/2:0/0:0), is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.
MG(0:0/20:0/0:0)
MG(0:0/20:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/20:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/20:0/0:0) is made up of one eicosanoyl(R2).
9'-Carboxy-alpha-tocotrienol
9-Carboxy-alpha-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-a-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Tocotrienols are members of the vitamin E family. An essential nutrient for the body, vitamin E is made up of four tocopherols (alpha, beta, gamma, delta) and four tocotrienols (alpha, beta, gamma, delta).Chemically, vitamin E is an antioxidant. One model for the function of vitamin E in the body is that it protects cell membranes, active enzyme sites, and DNA from free radical damage. Tocotrienols are natural compounds found in select vegetable oils, wheat germ, barley, saw palmetto, and certain types of nuts and grains. This variant of vitamin E only occur at very low levels in nature. While the majority of research on vitamin E has focused on alpha-tocopherol, studies into tocotrienols account for less than 1\\% of all research into vitamin E. 9-Carboxy-alpha-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-a-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
Glycerol trihexanoate
Glycerol trihexanoate is a probable constituent of fat Probable constituent of fats.
MG(0:0/i-20:0/0:0)
MG(0:0/i-20:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/i-20:0/0:0) is made up of one 18-methylnonadecanoyl(R2).
N-Lauroyl Tryptophan
N-lauroyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Aragest
bufalin
Dexanabinol
Proligestone
Ophiobolin C
A sesterterpenoid that is ophiobolane with a hydroxy group at position 3, oxo group at positions 5, formyl group at position 7, and double bonds at positions 7-8 and 19-20.
(3beta,20S)-3-Hydroxy-4,4,14-trimethylpregna-7,9(11)-diene-20-carboxylic acid|3beta-hydroxy-4,4,14alpha-trimethyl-5alpha-pregna-7,9(11)-diene-20S-carboxylic acid
N-(3-hydroxyisotetradecanoyl)anatabine
C24H38N2O2 (386.29331279999997)
(1R,2R,4R)-4-isobutyl-6,6,8,8-tetramethyl-2,3,4,8-tetrahydrochromene-5,7-dione-2-spiro-2-6,6-dimethyl-bicyclo[3.1.1]heptane|ficifolidione
(20S)-20-(N,N-dimethylamino)-3beta-(N-acetylamido)-5alpha-pregn-16-ene|16-dehydrosarcorine
(ent-15beta)-2-Methylpropenoyl-15-Hydroxy-16-kauren-19-oic acid|2-Methylpropenoyl-15-Hydroxy-16-kauren-19-oic acid
4-(1-methoxyethyl)-5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol
20-(N,N-dimethylamino)-3beta-(N-formylamino)-5alpha-pregn-2-en-4-one|hookerianamide H
C24H38N2O2 (386.29331279999997)
6beta-cinnamoyloxy-1beta,4alpha-dihydroxyeudesmane
(22E)-24-norcholesta-7,22-diene-3beta,5alpha,6beta-triol
3,17-dimethyl-18,19-dinor-17alpha-stigmasta-1,3,5,7,9,11,13-heptaene
Bourgeanic-Acid|Bourgeanic-saeure|xanthoric acid B
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-butanoate
3-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraenyl)thiophene-1-oxide
15,16-dihydroxy-9Z,12Z-octadecadienoic acid 2,3-dihydroxypropyl ester
24,25,26,27-tetranor-23-hydroxycycloartan-3-one|macrostachyoside B
(+)-17-hydroxyemericella-3E,7E,12Z,22-tetraen-16-oic acid|emericellene C
3-oxo-24,25,26,27,29-pentnor-5alpha-cycloart-23,21-olide|aphagrandinoid C
(+)-emericella-3E,7E,22-trien-17alpha-al-16-oic acid|emericellene D
(+)-12beta,17-epoxyemericella-3E,7E,22-trien-16-oic acid|emericellene B
(20S)-3beta-N-methyl-20-(N-acetyl-N-methylamino)-5alpha-pregn-14-ene
(20R,24R)-4,17beta-Dimethyl-18,19-dinorstigmast-1,3,5,7,9,11,13-heptaene
12-deacetoxy-12-oxo-deoxoscalarin|12-deacetoxy-12-oxodeoxoscalarin|12-ketodeoxoscalarin
Cyclobuxine
Cyclobuxine D is a steroid alkaloid. Cyclobuxine D is a natural product found in Buxus wallichiana and Buxus sempervirens with data available.
Ala Ala Ile Ile
Ala Ala Ile Leu
Ala Ala Leu Ile
Ala Ala Leu Leu
Ala Ile Ala Ile
Ala Ile Ala Leu
Ala Ile Ile Ala
Ala Ile Leu Ala
Ala Leu Ala Ile
Ala Leu Ala Leu
Ala Leu Ile Ala
Ala Leu Leu Ala
Ala Val Val Val
Gly Ile Val Val
Gly Leu Val Val
Gly Val Ile Val
Gly Val Leu Val
Gly Val Val Ile
Gly Val Val Leu
Ile Ala Ala Ile
Ile Ala Ala Leu
Ile Ala Ile Ala
Ile Ala Leu Ala
Ile Gly Val Val
Ile Ile Ala Ala
Ile Leu Ala Ala
Ile Val Gly Val
Ile Val Val Gly
Leu Ala Ala Ile
Leu Ala Ala Leu
Leu Ala Ile Ala
Leu Ala Leu Ala
Leu Gly Val Val
Leu Ile Ala Ala
Leu Leu Ala Ala
Leu Val Gly Val
Leu Val Val Gly
Val Ala Val Val
Val Gly Ile Val
Val Gly Leu Val
Val Gly Val Ile
Val Gly Val Leu
Val Ile Gly Val
Val Ile Val Gly
Val Leu Gly Val
Val Leu Val Gly
Val Val Ala Val
Val Val Gly Ile
Val Val Gly Leu
Val Val Ile Gly
Val Val Leu Gly
Val Val Val Ala
(5Z,7E)-2-oxa-9,10-seco-5,7,10(19)-cholestatrien-25-ol
3-Fluoro-9,10-secocholesta-5,7,10(19)-triene
HU-211
Tricaproin
A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.
Cryptomeridiol 11-rhamnoside
hu-210
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D020011 - Protective Agents
lyso-ornithine lipid
C21H42N2O4 (386.31444120000003)
alpha-N-(3-hydroxy-14-methyl-pentadecanoyl)-ornithine
C21H42N2O4 (386.31444120000003)
ascr#25
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,14R)-14-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#25
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-15-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
3-hydroxy-4-methylene-2-(n-eicos-11-yn-19-enyl)but-2-enolide
2-ethyl-2-[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate
2,5-Dihexyl-1,4-benzene-diboronic acid ethylene glycol ester
C22H36B2O4 (386.27995560000005)
1,1,4,4,7,7,10,10-OCTAMETHYL-2,3,4,7,8,9,10,12-OCTAHYDRO-1H-DIBENZO[B,H]FLUORENE
1-(DODECYLOXY)-4-((4-ETHYNYLPHENYL)ETHYNYL)BENZENE
hookerianamide H
C24H38N2O2 (386.29331279999997)
A steroid alkaloid that is 5alpha-pregn-2-ene-4-one substituted by a N-formylamino group at position 3 and a N,N-dimethylamino group at position 20. Isolated from Sarcococca hookeriana, it exhibits antiplasmodial activity and inhibitory activity against cholinesterase.
(2E,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
(2E)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
Octadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
C22H46O3Si (386.32160459999994)
Dexanabinol
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
DG(O-18:0/2:0/0:0)
2-Acetyl-1-octadecyl-sn-glycerol, or DG(O-18:0/2:0/0:0), is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 2-Acetyl-1-octadecyl-sn-glycerol is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. [HMDB]
MG(i-20:0/0:0/0:0)
MG(i-20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-20:0/0:0/0:0) is made up of one 18-methylnonadecanoyl(R1).
(3-Carboxy-2-pentadecanoyloxypropyl)-trimethylazanium
C22H44NO4+ (386.32701640000005)
[(2R)-3-carboxy-2-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-Carboxy-2-(3-oxotetradecanoyloxy)propyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-Carboxy-2-(13-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(11-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(10-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(8-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(9-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(7-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(3-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(4-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(5-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(6-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(12-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-carboxy-2-[(E)-12-carboxydodec-8-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-10-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-11-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-6-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-9-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-9-hydroxytetradec-6-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-10-hydroxytetradec-12-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-5-hydroxytetradec-3-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-8-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-4-hydroxytetradec-2-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(E)-2-(carboxymethyl)-2,16-dihydroxy-3-oxohexadec-4-enyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
(10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-1-ol
1-[2-(4-methylphenyl)ethyl]-N-[3-(4-methyl-1-piperazinyl)propyl]-5-oxo-3-pyrrolidinecarboxamide
2-[2-[[5-[1-(Dimethylamino)propyl]-4-[2-(4-morpholinyl)ethyl]-1,2,4-triazol-3-yl]thio]ethylamino]ethanol
1-Cyclohexyl-4-[1-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]propyl]piperazine
C21H31FN6 (386.25940979999996)
N-[[(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
(3R,22R)-3,22-dihydroxytricosanoic acid
A dihydroxy monocarboxylic acid that is tricosanoic acid in which the pro-R hydrogens at positions 3 and 22 are replaced by hydroxy groups.
Pentadecanoyl-L-carnitine (chloride)
C22H44NO4+ (386.32701640000005)
(3R)-3,22-dihydroxytricosanoic acid
A dihydroxy monocarboxylic acid that is tricosanoic acid in which the pro-R hydrogen at position 3 and and one of the hydrogens of the terminal methyl group are replaced by hydroxy groups.
[3-carboxy-2-[(Z)-3-hydroxytetradec-9-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(1S)-3-carboxy-1-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
(1-Hydroxy-3-propanoyloxypropan-2-yl) hexadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) tetradecanoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
1-icosanoylglycerol
A 1-monoglyceride resulting from the formal condensation of the carboxy group of icosanoic acid with one of the primary hydroxy groups of glycerol.
(11Z,14Z,17Z,20Z,23Z)-hexacosapentaenoic acid
A very long-chain omega-3 fatty acid that is hexacosanoic acid having five double bonds located at positions 11, 14, 17, 20, 23 (the 11Z,14Z,17Z,20Z,23Z-isomer).
TG(18:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(20:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2s,3s)-3-{[(1s)-1-[bis(4-aminobutyl)carbamoyl]-3-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
10-hydroxy-16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-en-8-one
(6e,8e,11e,14e)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(2s,3r,4r,5r,6s)-2-({2-[(2r,4ar,8r,8ar)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
(1's,2r,4's,5'r,9's,10'r,13'r)-5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-5'-ylmethyl (2z)-2-methylbut-2-enoate
5-(hydroxymethyl)-3-(icos-15-en-11,13-diyn-1-yl)oxolan-2-one
4-hydroxy-4,6-dimethyl-6-(12-phenyldodec-10-en-1-yl)oxan-2-one
(1r,3s,4r,6r,7s,11s,12r)-4,6-dihydroxy-1,4-dimethyl-12-[(2s)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(4r)-4-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-hydroxy-7,7,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]pentanal
(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one
(2s,3s,3ar,5as,9as,9br)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
(1r,4s,6r,9r,10s,13r,15r)-6-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (2z)-2-methylbut-2-enoate
(4s,6e,8e,10s,11e,14e,16s)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(1r,5as,5br,7as,11as,11br,13as,13bs)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-chryseno[1,2-c]furan-13-one
(1s,2r,4r,5s,11s,14s,17r,18s)-11-(hydroxymethyl)-17-isopropyl-4,14-dimethylpentacyclo[9.7.0.0²,⁴.0⁵,⁹.0¹⁴,¹⁸]octadec-8-ene-8-carboxylic acid
(8as,9r,10as)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}carboximidic acid
C24H38N2O2 (386.29331279999997)
(5as,5br,7as,11as,11br,13r,13as,13br)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(1s,3r,6s,8r,11s,12r,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(1s,4r,5r,9r,10r,13s,15r)-5,9-dimethyl-15-{[(2z)-2-methylbut-2-en-1-yl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl 2-methylbut-2-enoate
n-[(3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]ethanimidic acid
(4s,5as,5br,7as,11as,11br,13r,13as)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4,13-diol
(1s,3r,8r,11s,12s,15r,16r)-15-[(2r)-4-hydroxybutan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one
12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
(4s,5as,5br,7as,11as,11br,13s,13ar)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-b]furan-4,13-diol
5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4,13-diol
(1s,3r,6r,8r,11r,12r,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(2s,3r,4r,5r,6r)-2-ethyl-2-hydroxy-6-isopropyl-3,5-dimethyloxan-4-yl (2s,3s,4r)-3-hydroxy-2,4-dimethyl-5-oxoheptanoate
6-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 2-methylbut-2-enoate
6-[4-(2-acetyl-5-methylcyclopent-2-en-1-yl)butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1r,4s,5r,9r,10s,13r,16s)-5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl (2e)-2-methylbut-2-enoate
(1r,3s,4r,7s,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1s,3r,11r,12r,13s,14s,19s)-12-hydroxy-1,11,14,18,18-pentamethyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicos-5(9)-en-8-one
(1r,3ar,5ar,6r,7s,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
5-[5-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)-3-methylpent-2-en-1-yl]-4-(hydroxymethyl)-5h-furan-2-one
(2r)-2-amino-n,3-dihydroxy-n-[(14s)-14-methyl-3,10-dioxohexadecyl]propanamide
4-{6-hydroxy-7,7,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}pentanal
(1's,2r,4's,6'r,9's,10'r,13'r)-5',5',9'-trimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-6'-yl (2z)-2-methylbut-2-enoate
(2s,3s)-3-(methoxycarbonyl)-2-tetradecylpentanedioic acid
(1s,2r,5r,7s,9s,10s,12r,13s,16s)-10-hydroxy-16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-en-8-one
(6e,10s,14e)-17-(furan-3-yl)-2,6,10,14-tetramethylheptadeca-6,14-diene-4,12-dione
(4s,6e,8e,10s,11e,14e,16r)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(1s,3r,6r,8r,11s,12s,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
4-[(1r)-2-[(1r,4ar,4bs,8as,10as)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]-1-hydroxyethyl]-5h-furan-2-one
(3r,3as,6r,7as)-6-[(2r)-4-[(1s,5r)-2-acetyl-5-methylcyclopent-2-en-1-yl]butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1r,3r,4r,6r,7s,8e,11s,12r)-3,6-dihydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(17e)-18-(2h-1,3-benzodioxol-5-yl)octadec-17-en-2-one
(1s,3e,5r,7e,11e)-1-(furan-3-yl)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraene-1,5-diol
(7r,8as,9r,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
n-[(1s)-1-[(1s,3br,5as,7s,9as,9bs,11ar)-9a,11a-dimethyl-7-(methylamino)-1h,2h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide
(1s,3r,6r,7s,9e,13s,15r,16s)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
(1r,3ar,5ar,6r,7r,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(2s,3s,4e,6e)-7-[(1as,2ar,3s,4r,6ar,7ar)-4-[(2z)-but-2-en-2-yl]-5,7a-dimethyl-1ah,2h,2ah,3h,4h,6ah,7h-naphtho[2,3-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydropyridin-2-yl)-octahydro-2h-quinoline
13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(2s)-2-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]propanoic acid
2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(6r,7e,16z)-24-methylpentacosa-7,16-dien-2,4-diyne-1,6-diol
(1r,4as,4br,6as,10as,10br,12s,12as)-12-hydroxy-4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde
(1s,3r,6s,8s,11s,12s,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(1r,3z,7z,11s,12r,15s)-12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-diol
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}ethanimidic acid
(1's,2s,3s,3'r,5r,7'r,10'r,11'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecan]-13'-en-12'-one
2-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,3s,3as,5as,9bs)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
1-(furan-3-yl)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraene-1,5-diol
4-[(1r)-2-[(1r,4ar,4bs,10as)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]-1-hydroxyethyl]-5h-furan-2-one
4-[(1r)-1-methoxyethyl]-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol
(3r,3as,6r,7as)-6-[4-(2-acetyl-5-methylcyclopent-2-en-1-yl)butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1s,3r,6r,7s,9e,13r,15r,16r)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
(4r,6r)-4-hydroxy-4,6-dimethyl-6-[(10e)-12-phenyldodec-10-en-1-yl]oxan-2-one
3-({1-[bis(4-aminobutyl)carbamoyl]-3-methylbutyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid
(5r)-5-[(2e)-5-[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]-4-(hydroxymethyl)-5h-furan-2-one
(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(2s,3s,4e,6e)-7-[(1as,2ar,3s,4r,6ar,7ar)-4-[(2e)-but-2-en-2-yl]-5,7a-dimethyl-1ah,2h,2ah,3h,4h,6ah,7h-naphtho[2,3-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
(1r,3e,7e,11s,12r,15s)-12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
7-hydroxy-1-(1-hydroxypropan-2-yl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(2s,3s,4e,6e)-7-[(1ar,2r,3s,3as,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-1a,6-dimethyl-2h,3h,3ah,4h,7h,7ah,7bh-naphtho[1,2-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
(2r,3r,4r,5r)-4-{[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}hexane-1,2,3,5,6-pentol
(2s,3r,4s,5r,6r)-2-({2-[(2r,5s,6r,7r,10s)-7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
4-(1-methoxyethyl)-5-methyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol
(1'r,2r,4r,5's)-6,6,6',6',8,8-hexamethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-5,7-dione
(1s,3e,7e,11s,15s)-12-(hydroxymethyl)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7,12-triene-15-carboxylic acid
12,16-dimethyl-6-(methylamino)-15-[1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
2-[(2-{7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl}propan-2-yl)oxy]-6-methyloxane-3,4,5-triol
(3r,3as,6r,7as)-6-[(2r)-4-[(1r,5r)-2-acetyl-5-methylcyclopent-2-en-1-yl]butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(2s,3r,4s,5r,6r)-2-({2-[(2r,5s,6s,7s,10s)-7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carboxylic acid
3,6-dihydroxy-1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1r,3s,4r,7r,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(2r)-2-[(2s)-1-methoxy-1-oxohexadecan-2-yl]butanedioic acid
(7s,8ar,9r,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
(1r,3s,4r,8e)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1s,3r)-2,2-dimethyl-4-methylidene-3-[(3e,7e)-3,8,12-trimethyltrideca-3,7,11-trien-1-yl]cyclohexyl formate
4-[(7e)-4,8-dimethyl-10-(2,6,6-trimethylcyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
4-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]hexane-1,2,3,5,6-pentol
(1r,3e,7e,11r,12s,15s)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carboxylic acid
(15e,17e)-9,10,12,13-tetrahydroxyhenicosa-15,17-dienoic acid
(2s,3s,3ar,5as,9as,9br)-3-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
n-[(1s,3as,3bs,5ar,9ar,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]carboximidic acid
C24H38N2O2 (386.29331279999997)
(2r,3r,3as,5ar,9ar,9bs)-3-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
(2s,3s)-3-{[(1r,2r)-1-[bis(4-aminobutyl)carbamoyl]-2-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
3-[2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
1-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-chryseno[1,2-c]furan-13-one
(7s,8as,9s,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
12-(hydroxymethyl)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7,12-triene-15-carboxylic acid
5',5',9'-trimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-6'-yl 2-methylbut-2-enoate
(2s)-2-amino-n,3-dihydroxy-n-(15-methyl-3,10-dioxohexadecyl)propanamide
4-[2-(4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl)-1-hydroxyethyl]-5h-furan-2-one
2-ethyl-2-hydroxy-6-isopropyl-3,5-dimethyloxan-4-yl 3-hydroxy-2,4-dimethyl-5-oxoheptanoate
13-hydroxy-5b,8,8,11a,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one
(2s,3s,3as,5as,9as,9bs)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
17-(furan-3-yl)-2,6,10,14-tetramethylheptadeca-6,14-diene-4,12-dione
5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-5'-ylmethyl 2-methylbut-2-enoate
4-[(3e,7e)-4,8-dimethyl-10-(2,6,6-trimethylcyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
(7r,8as,9r,10as)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
(8r,13r,15s)-13-ethenyl-11-ethyl-8-hydroxy-15-methoxy-11-azahexacyclo[7.6.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁶]octadecane-4-carboximidic acid
5,9-dimethyl-15-[(2-methylbut-2-en-1-yl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
n-[(1s,3as,3bs,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]carboximidic acid
C24H38N2O2 (386.29331279999997)